- Solid
- Liquid
Xylitol market was valued at USD 701.5 Million in 2022 and is poised to grow at a CAGR of 4.3% over 2023-2029. Xylitol is a polyalcohol used as a low-calorie substitute for sugar and a food additive approved by FDA. Xylitol has a low glycemic index (GI) thus blood glucose or insulin spike in the blood is maintained. According to USDA, xylitol consists of 2.5 calories per gram compared to granulated sugar consisting of 3.87 calories per gram. Moreover, according to a research article published in 2023 by Nature, xylitol is anti-carcinogenic and it inhibits the transmission of cariogenic oral flora from mother to child during the discrete window of infectivity (3-31 months of age) leading to effective prevention of caries development. Xylitol market is currently flourishing. According to an article by Nature, xylitol production currently is over 10,000 tonnes per year, contributing majorly to the dental, pharmaceutical, confectionary and cosmetic markets. A study conducted by the Iranian Journal of Microbiology showed that 75% of cavity-forming bacteria starve and die off by regular use of xylitol products. Other than that, in the prevention and treatment of Type 2 Diabetes also xylitol plays an important role. The similarity of xylitol texture, flavor and appearance to sugar; its low-calorie content, prevention of dental plaque and dry mouth are some of the factors contributing to the upsurge of the xylitol market. The popularity of low-calorie dental products like breath mints, mouthwash, and toothpaste; the substitution of sugar sweeteners by xylitol in cough syrups, chewable tablets, and lozenges are expected to drive the xylitol market.
Xylitol Market Key Developments:
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Xylitol is extensively exploited for its antimicrobial activity for respiratory tract hygiene. The number of nasal coagulases significantly lowers with the use of xylitol formulations. It acts by reducing ASL- airway surface liquid salt concentration and improving the microbial defence in the respiratory pathway. Burkholderia cepacian which is a pulmonary pathogen that prevails after lung transplantation, when treated with xylitol inhibited its growth up to 65%, which is quite crucial for lung transplant. According to WHO, each year almost 6,50,000 mishaps are caused by respiratory diseases, with Influenza A virus being the leading one among all. According to a research article from 2020, xylitol along with ginseng has a synergistic effect and works by ameliorating Influenza virus infection. Xylitol with its antiviral activity has proved to be a promising solution for respiratory disease thus enhancing the Xylitol market extensively.
North America is currently driving the xylitol market
Cheaper substitutes to xylitol, sometimes the development of side effects such as diarrhea and gas, development of tumors in pet animals on its consumption tends to decrease the xylitol market.
DuPont (Danisco) (USA), Futaste Pharmaceutical Co., Ltd. (China), Roquette Freres (France), Zhejiang Huakang Enterprise Co., Ltd. (China), Nova Green Inc (Canada) are some of the key players of xylitol market.
The global xylitol market is expected to grow at 4.3% CAGR over the forecast period 2023-2029.
The global xylitol market is valued at USD 701.5 million in 2022.